You are here
Breast Cancer Integrative Oncology: Prospective Matched Controlled Outcomes Study NIH/NCCAM (R01)
In 2010 Bastyr, along with the Hutchinson Center, received a $3.1 million grant for the study of complementary and integrative care for breast cancer. The grant, awarded by the National Institutes of Health (NIH), National Center for Complementary and Alternative Medicine (NCCAM), funds a project entitled "Breast Cancer Integrative Oncology: Prospective Matched Controlled Outcomes Study."
The five-year award will allow clinical investigators at the Bastyr University Research Institute and the Hutchinson Center to undertake a rigorous outcomes-based research study. Investigators will track clinical outcomes for participants with breast cancer who, in addition to standard conventional care, receive integrative care at BIORC and other integrative oncology clinical sites in western Washington. Those outcomes will then be compared with outcomes for participants with breast cancer who do not receive integrative care along with conventional care. This study will compare the 'disease free survival' and quality of life of participants treated at an integrative oncology clinic to the experience of similar breast cancer patients living in Washington state who do not include complementary, alternative or integrative therapies in their treatment
For more information visit www.clinicaltrials.gov.
Our research partnership with the Hutchinson Center will tell us how our participants do over the long term and help us to continuously improve our care and therapies.
Call the Clinical Research Center at 425.602.3311 for further information.